NDC 51662-1334
PROCAINAMIDE HCI
Procainamide Hci
PROCAINAMIDE HCI is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Procainamide Hydrochloride.
| Product ID | 51662-1334_8192d79d-da2c-2532-e053-2991aa0ae8ad |
| NDC | 51662-1334 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PROCAINAMIDE HCI |
| Generic Name | Procainamide Hci |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2019-02-10 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA089069 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | PROCAINAMIDE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | Antiarrhythmic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |